Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Circulation

• Publication date

  1985-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.72.4.853PMID 4040821
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isovolumic relaxation period in hypertrophic cardiomyopathy.

  1984cited by this paper
• Diastolic properties of the left ventricle in normal adults and in patients with third heart sounds.

  1984cited by this paper
• Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.

  1984cited by this paper
• Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: altered left ventricular loading or improved muscle inactivation?

  1983cited by this paper
• Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe.

  1983cited by this paper
• Influence of verapamil therapy on left ventricular performance at rest and during exercise in hypertrophic cardiomyopathy.

  1983cited by this paper
• Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil.

  1983cited by this paper
• Diastolic function in hypertrophic cardiomyopathy: effects of propranolol and verapamil on diastolic stiffness.

  1983cited by this paper
• [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].

  1982cited by this paper
• Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise.

  1982cited by this paper
• Modification of Abnormal Left Ventricular Diastolic Properties by Nifedipine in Patients with Hypertrophic Cardiomyopathy

  1982cited by this paper
• Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients.

  1981cited by this paper
• Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration.

  1981cited by this paper
• Effects of Verapamil on Left Ventricular Systolic Function and Diastolic Filling in Patients with Hypertrophic Cardiomyopathy

  1981cited by this paper
• Verapamil therapy: a new approach to pharmacologic treatment of hypertrophic cardiomyopathy.

  1980cited by this paper
• Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy.

  1980cited by this paper
• Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: an echocardiographic study.

  1980cited by this paper
• Treatment of hypertrophic obstructive cardiomyopathy with verapamil

  1980cited by this paper
• Hypertrophic cardiomyopathy: subclassification by m mode echocardiography.

  1980cited by this paper
• Diastolic pressure-volume relations in the diseased heart.

  1980cited by this paper
• Hypertrophic cardiomyopathy: a discussion of nomenclature.

  1979cited by this paper
• Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.

  1979cited by this paper
• Instrumentation and data processing in cardiovascular nuclear medicine: evaluation of ventricular function.

  1979cited by this paper
• Treatment of hypertrophic obstructive cardiomyopathy with verapamil.

  1979cited by this paper
• Left-ventricular peak ejection rate, filling rate, and ejection fraction--frame rate requirements at rest and exercise: concise communication.

  1979cited by this paper
• Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.

  1979cited by this paper
• Left ventricular relaxation and filling in hypertrophic cardiomyopathy. An echocardiographic study.

  1978cited by this paper
• Echocardiographic Assessment of Left Ventricular Filling and Septal and Posterior Wall Dynamics in Idiopathic Hypertrophic Subaortic Stenosis

  1978cited by this paper
• Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study.

  1977cited by this paper
• Asymmetric septal hypertrophy.

  1976cited by this paper
• Asymmetric septal hypertrophy.

  1976cited by this paper
• Diastolic properties of the left ventricle.

  1976cited by this paper
• Left ventricular compliance: mechanisms and clinical implications.

  1976cited by this paper
• Dynamic Determinants of Left Ventricular Diastolic Pressure‐Volume Relations in Man

  1975cited by this paper
• Left ventricular volumes and compliance in hypertrophic cardiomyopathy.

  1974cited by this paper
• Asymmetric Septal Hypertrophy: Echocardiographic Identification of the Pathognomonic Anatomic Abnormality of IHSS

  1973cited by this paper
• Effects of Changes in Body Position on the Severity of Obstruction to Left Ventricular Outflow in Idiopathic Hypertrophic Subaortic Stenosis

  1966cited by this paper
• Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients

  1964cited by this paper
• The Circulatory Response of Patients with Idiopathic Hypertrophic Subaortic Stenosis to Nitroglycerin and to the Valsalva Maneuver

  1964cited by this paper

• Beta-Blocker (Bisoprolol) vs Calcium-Channel Blocker (Verapamil) in Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Triple-Crossover Physiologic Trial.

  2026cites this paper
• Advances in Cardiovascular Pharmacotherapy. I. Cardiac Myosin Inhibitors.

  2025cites this paper
• Guías mexicanas 2024 para el diagnóstico y tratamiento de la miocardiopatía hipertrófica

  2025cites this paper
• Evolving Strategies for Management of Obstructive Hypertrophic Cardiomyopathy.

  2024cites this paper
• Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy.

  2022cites this paper
• Current therapies for hypertrophic cardiomyopathy: a systematic review and meta‐analysis of the literature

  2022cites this paper
• Cardiopulmonary Exercise Test in Patients with Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis

  2021cites this paper
• 2020 Clinical practice guidelines for Hypertrophic cardiomyopathy

  2021cites this paper
• Evaluation of Diastolic Function by Radionuclide Techniques

  2021cites this paper
• Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy

  2019cites this paper
• Title Decreasing the Pressure Gradient of the Left Ventricular Outflow Tract by Single-lead VDD Pacing in a Patient with Hypertrophic Obstructive Cardiomyopathy

  2019cites this paper
• Inherited Cardiac Muscle Disorders: Hypertrophic and Restrictive Cardiomyopathies

  2018cites this paper
• Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry

  2018cites this paper
• Medical Therapy: From Beta-Blockers to Disopyramide

  2018cites this paper
• Impact of drugs on intradialytic hypotension: Antihypertensives and vasoconstrictors

  2017cites this paper
• Assessment of Diastolic Function in Congenital Heart Disease

  2017cites this paper
• [Modern approaches to the problem of hypertrophic cardiomyopathy].

  2016cites this paper
• Can serial changes of diastolic dysfunction signal incremental risk of chemotherapy-induced heart failure missed by the timing of declining LV ejection fraction?

  2016cites this paper
• The Established Therapies: HF-PEF and HF-REF

  2016cites this paper
• Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?

  2016cites this paper
• Impacto pronóstico de la fibrilación auricular en la insuficiencia cardíaca desde su diagnóstico inicial

  2016cites this paper
• Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.

  2015cites this paper
• Medical Therapy: From Beta–Blockers to Disopyramide

  2015cites this paper
• Effects of flecainide on left ventricular pressure gradient and symptoms in obstructive hypertrophic cardiomyopathy: a comparison of flecainide and disopyramide

  2015cites this paper
• Imaging in hypertrophic cardiomyopathy. Expert consensus statement of the Polish Clinical Forum for Cardiovascular Imaging

  2015cites this paper
• Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population

  2014influential citation
• Mechanisms and medical management of exercise intolerance in hypertrophic cardiomyopathy.

  2014cites this paper
• Spirito–Maron Echocardiographic Score: A Marker for Morphological and Physiological Assessment of Patients with Hypertrophic Cardiomyopathy

  2014influential citation
• Management of hypertrophic cardiomyopathy.

  2014cites this paper
• Calcium Channel Blockers and Outcomes in Older Patients With Heart Failure and Preserved Ejection Fraction

  2014cites this paper
• STUDY OF DIASTOLIC FUNCTION IN ASYMPTOMATIC HYPERTENSIVES IN TERTIARY CARE CENTRE

  2014cites this paper
• ASSES S MENT OF DIASTOLIC FUNCTION BY COMBINED TRNSMITRAL AND PULMO N ARY VENOUS FLOW VELOCITY CURVES

  2014cites this paper
• Hypertension, Diastolic dysfunction, Echocardiography, E/A ration, Transmitral flow velocity.

  2014cites this paper
• Diastolic function, pseudonormal pattern, E/A ratio, echocardiography.

  2014cites this paper
• Cardiomyopathies encountered commonly in the teenage years and their presentation.

  2014cites this paper
• Arrhythmias and Hypertrophic Cardiomyopathy

  2014cites this paper
• Diagnóstico y tratamiento farmacológico de la insuficiencia cardiaca crónica. Una revisión necesaria. Diagnosis and farmacological treatment of the chronic heart failure. A necessary revision.

  2013cites this paper
• Influencia pronóstica del estado nutricional en el paciente con insuficiencia cardiaca

  2013cites this paper
• Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment

  2013cites this paper
• 11. Hypertrophic Cardiomyopathy

  2013cites this paper
• Medical Treatment of Hypertension in Patients with Heart Failure with Preserved Ejection Fraction

  2013cites this paper
• Hypertrophic cardiomyopathy

  2013cites this paper
• Heart Failure With a Normal Left Ventricular Ejection Fraction: Epidemiology, Pathophysiology, Diagnosis and Management

  2013cites this paper
• Severe hypertrophic cardiomyopathy and heart failure caused by multiple mutations: from molecular pathogenesis to pharmacological intervention

  2013cites this paper
• Heart Failure With a Normal Ejection Fraction: Treatments for a Complex Syndrome?

  2012cites this paper
• Atrial Functions Assessed by Colour Doppler Myocardial Imaging in Hypertrophic Cardiomyopathy

  2012cites this paper
• Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

  2012cites this paper
• Hypertrophic cardiomyopathy.

  2011cites this paper
• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci

  2011cites this paper
• Genotype-phenotype correlations and genetic family screening in hypertrophic cardiomyopathy

  2011cites this paper
• Ventricular-vascular interaction in heart failure.

  2011cites this paper
• American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomograph

  2011cites this paper
• Hypertrophic Cardiomyopathy in a Young Adult with RV Aneurysm: Report of a Rare Finding and Review of the Literature

  2011cites this paper
• Negative ionotropic agents for the treatment of left ventricular outflow tract obstruction due to sigmoid septum and concentric left ventricular hypertrophy.

  2011cites this paper
• AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy : Executive summary

  2011cites this paper
• Nuclear cardiac imaging in hypertrophic cardiomyopathy

  2011cites this paper
• 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cites this paper
• 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cites this paper
• Exercise intolerance.

  2011cites this paper
• Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy Endorsed by the American Society of Nuclear Cardiology , Society for Cardiovascular Magnetic Resonance , and Society of Cardiovascular Computed Tomography

  2011cites this paper
• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cites this paper
• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cites this paper
• Foundation/American Heart Association Task Force on Practice Guidelines Cardiomyopathy : A Report of the American College of Cardiology 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic

  2011cites this paper
• Inherited Myocardial Diseases

  2010cites this paper
• Heart failure with preserved ejection fraction in older adults.

  2009cites this paper
• Hypertension and cardiac failure in its various forms.

  2009cites this paper
• Diastolic dysfunction and heart failure with preserved ejection fraction: rationale for RAAS antagonist/CCB combination therapy.

  2009cites this paper
• Ventricular-vascular interaction in heart failure.

  2008cites this paper
• Chapter 17 – Exercise Intolerance in Diastolic Heart Failure

  2008cites this paper
• General Treatment of Diastolic Heart Failure

  2008cites this paper
• Exercise intolerance.

  2008cites this paper
• [Effects of nicotine on left ventricular diastolic function in patients with coronary disease. An echocardiographic study].

  2008cites this paper
• [The effect of verapamil on left ventricular diastolic function in coronary heart disease].

  2008cites this paper
• Chapter 9 – Evaluation of Diastolic Function by Radionuclide Techniques

  2008cites this paper
• [Reproducible (latent) obstruction of the left ventricular outflow tract].

  2008cites this paper
• Therapeutic options in hypertrophic cardiomyopathy: A pediatric perspective

  2008cites this paper
• Ποσοτική ανάλυση της μορφολογίας του κύματος Τ για τη διαστρωμάτωση του βραχυπρόθεσμου αρρυθμικού κινδύνου σε ασθενείς με οξύ έμφραγμα του μυοκαρδίου

  2008influential citation
• Treatment of hypertension in heart failure with preserved ejection fraction: role of the kidney.

  2008cites this paper
• Diastolic heart failure in the elderly.

  2007cites this paper
• Diastolic heart failure in the elderly.

  2007cites this paper
• phosphate pools in cardiomyopathic Syrian hamster L-carnitine treatment improves cardiac performance and restores high- energy

  2007cites this paper
• 8 – Management of Heart Failure

  2007cites this paper
• Practice Guidelines Consensus Documents and the European Society of Cardiology Committee for

  2007cites this paper
• Pharmacologic Management of Heart Failure in the Ambulatory Setting

  2007cites this paper
• Congestive Heart Failure in the Elderly

  2007cites this paper
• Review of noninvasive imaging for hypertrophic cardiac syndromes and restrictive physiology.

  2006cites this paper
• Hypertension and heart failure: Diagnosis and management

  2006cites this paper
• êÖäéåÖçÑÄñàà èé ÑàÄÉçéëíàäÖ à ãÖóÖçàû ïêéçàóÖëäéâ ëÖêÑÖóçéâ çÖÑéëíÄíéóçéëíà (2005) ꇷӘ‡fl "ÛÔÔ‡ Ö‚ÓÔÂÈÒÍÓ"Ó Ó·˘ÂÒÚ‚‡ ͇‰ËÓÎÓ"Ó‚ ÔÓ ‰Ë‡"ÌÓÒÚËÍÂ Ë Î˜ÂÌ˲ iÓÌ˘ÂÒÍÓÈ Ò‰˜ÌÓÈ Ì‰ÓÒÚ‡ÚÓ˜ÌÓÒÚË

  2006cites this paper
• Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy.

  2006cites this paper
• Heart failure with preserved ejection fraction.

  2006cites this paper
• Evaluation and management of patients with heart failure and preserved left ventricular ejection fraction.

  2006cites this paper
• Effect of losartan and hydrochlorothiazide on exercise tolerance in exertional hypertension and left ventricular diastolic dysfunction.

  2006cites this paper
• Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction

  2006cites this paper
• Effects of diltiazem on hemodynamic variables and ventricular function in healthy horses.

  2005cites this paper
• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

  2005cites this paper
• Canine Left Ventricle

  2005cites this paper
• Diastolic heart failure: a review and primary care perspective.

  2005cites this paper
• Wytyczne postępowania Europejskiego Towarzystwa Kardiologiczne- go (European Society of Cardiology - ESC) Uaktualnienie 2005

  2005cites this paper
• HYPERTROPHIC CARDIOMYOPATHY Effects of long-term treatment with amiodarone on exercise hemodynamics and left ventricular relaxation in patients with hypertrophic cardiomyopathy

  2005cites this paper
• Guidelines for the diagnosis and treatment of Chronic Heart Failure: full text (update 2005) The Task Force for the diagnosis and treatment of CHF of the European Society of Cardiology

  2005cites this paper